Dr Sabrina Chiara Cecere, born in Caserta, Italy, in 1982, earned her MD in 2006 and specialised in Medical Oncology in 2011 at the "L. Vanvitelli" University of Naples, Italy. Since then, she has been affiliated with the National Cancer Institute (NCI) of Naples, where she serves as a medical researcher and oncologist in the Department of Uro-Gynaecological Experimental Medicine.

Dr Cecere is dedicated to advancing the treatment of gynaecological cancers, actively participating as Principal Investigator in many clinical trials  exploring innovative therapies, biomarkers and therapeutic combinations aimed at improving patients’ outcomes. At the NCI "G. Pascale" of Naples, she covers the role of National representative for Gender Medicine, Coordinator of the current research line. As a proactive member of oncologic organisations/societies, such as ESMO, ESGO, AIOM, and the MITO group, Dr Cecere collaborates with leading researchers and practitioners to foster innovation in cancer care. Since 2011 she is the coordinator of the Multidisciplinary Oncology Group for Ovarian Tumours in the Campania Region in Italy and also co-author of the National Ovarian Cancer Guidelines for the AIOM society. She is one of the training board members of MITO group and one of the board members of the ENGOT FLI group (European Network for Gynaecological Oncological Trial Groups Future Lead Investigators). Since 2024 Dr Cecere has been Member of the Equity, Diversity and Inclusion (EDI) in Clinical Research board for the Gynaecologic Cancer Intergroup (GCIG). Besides her clinical and research roles, Dr Cecere is an advocate for gender equality in healthcare, actively participating in initiatives aimed at promoting diversity and inclusion within clinical research.